- Home
- EQX vs RVTY Comparison
EQX vs RVTY Comparison
Compare EQX & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EQX | RVTY |
|---|---|---|
| Founded | 2007 | 1937 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Laboratory Analytical Instruments |
| Sector | Basic Materials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.9B | 11.6B |
| IPO Year | 2018 | 1994 |
Fundamental Metrics
Financial Performance| Metric | EQX | RVTY |
|---|---|---|
| Price | $9.28 | $106.23 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 16 |
| Target Price | $17.00 | ★ $109.67 |
| AVG Volume (30 Days) | ★ 14.2M | 1.4M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | 0.11% | ★ 0.34% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.36 |
| Revenue | N/A | ★ $3,311,822,000.00 |
| Revenue This Year | $102.84 | $6.37 |
| Revenue Next Year | $15.55 | $5.10 |
| P/E Ratio | ★ $137.41 | $294.15 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.64 | $81.22 |
| 52 Week High | $18.96 | $118.30 |
Technical Indicators
Market Signals| Indicator | EQX | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 32.01 | 62.27 |
| Support Level | N/A | $94.93 |
| Resistance Level | $15.44 | $118.30 |
| Average True Range (ATR) | 0.57 | 3.71 |
| MACD | -0.06 | -0.06 |
| Stochastic Oscillator | 2.83 | 92.50 |
Price Performance
Historical ComparisonAbout EQX Equinox Gold Corp.
Equinox Gold Corp is a mining company engaged in the operation, acquisition, exploration, and development of mineral properties, with a focus on gold. The company operates gold mines and a clear plan to increase production by advancing the pipeline of growth projects. Geographically, the company operates in the Canada, United States, Mexico, and others. The majority of its revenue is generated from Canada.
About RVTY Revvity Inc.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.